Cargando…

Development and Validation of Web-Based Nomograms to Predict Postoperative Invasive Component in Ductal Carcinoma in Situ at Needle Breast Biopsy

OBJECTIVES: Although sonography-guided core needle biopsy is a highly targeted method, there is a possibility of an invasive component after surgical excision of ductal carcinoma in situ (DCIS) of the breast. This study was performed to develop and validate nomograms to predict the postoperative inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Seong Cheol, Chang, Myung-Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Medical Informatics 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030059/ https://www.ncbi.nlm.nih.gov/pubmed/24872914 http://dx.doi.org/10.4258/hir.2014.20.2.152

Ejemplares similares

Ductal carcinoma in situ in core needle biopsies and its association with extensive in situ component in the surgical specimen
por: Barbalaco Neto, Guerino, et al.
Publicado: (2012)

A Simple Model to Assess the Probability of Invasion in Ductal Carcinoma In Situ of the Breast Diagnosed by Needle Biopsy
por: Coufal, Oldřich, et al.
Publicado: (2014)

An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast
por: Kim, Sanghwa, et al.
Publicado: (2019)

The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ
por: Yoon, Ga Young, et al.
Publicado: (2020)

Screen-detected ductal carcinoma in situ - fine needle aspiration versus core biopsy
por: Lee, CM, et al.
Publicado: (2009)

Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy
por: Lee, Kwan Ho, et al.
Publicado: (2019)

Development and Validation of a Simple-to-Use Nomogram for Predicting the Upgrade of Atypical Ductal Hyperplasia on Core Needle Biopsy in Ultrasound-Detected Breast Lesions
por: Huang, Yun-Xia, et al.
Publicado: (2021)

A clinical radiomics nomogram preoperatively to predict ductal carcinoma in situ with microinvasion in women with biopsy-confirmed ductal carcinoma in situ: a preliminary study
por: Huang, Zhou, et al.
Publicado: (2023)

Predicting Underestimation of Invasive Cancer in Patients with Core-Needle-Biopsy-Diagnosed Ductal Carcinoma In Situ Using Deep Learning Algorithms
por: Do, Luu-Ngoc, et al.
Publicado: (2022)

Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
por: Si, Jing, et al.
Publicado: (2019)

Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
por: Si, Jing, et al.
Publicado: (2019)

Development and Evaluation of a Prediction Model for Underestimated Invasive Breast Cancer in Women with Ductal Carcinoma In Situ at Stereotactic Large Core Needle Biopsy
por: Diepstraten, Suzanne C. E., et al.
Publicado: (2013)

Prediction of Sentinel Lymph Node Metastasis in Breast Ductal Carcinoma In Situ Diagnosed by Preoperative Core Needle Biopsy
por: Zhang, Kai, et al.
Publicado: (2020)

Diagnostic underestimation of atypical ductal hyperplasia and ductal carcinoma in situ at percutaneous core needle and vacuum-assisted biopsies of the breast in a Brazilian reference institution
por: Badan, Gustavo Machado, et al.
Publicado: (2016)

Breast Lesions Diagnosed as Ductal Carcinoma In Situ by Ultrasound-Guided Core Needle Biopsy: Risk Predictors for Concomitant Invasive Carcinoma and Axillary Lymph Node Metastasis
por: Liu, Yanbiao, et al.
Publicado: (2021)

Comprehensive analysis of the 21-gene recurrence score in invasive ductal breast carcinoma with or without ductal carcinoma in situ component
por: Zeng, Yufei, et al.
Publicado: (2020)

Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ
por: Ahn, Hye Shin, et al.
Publicado: (2020)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Ductal Carcinoma In Situ and Sentinel Lymph Node Biopsy
por: Son, Bok Kyoung, et al.
Publicado: (2011)

Sentinel Node Biopsy in Ductal Carcinoma in Situ: Is it Justifiable?
por: Al-Shurbasi, Nour, et al.
Publicado: (2021)

Significance of boost radiotherapy in early invasive ductal breast cancer with ductal carcinoma in situ component under negative surgical margins
por: Shimizu, Naoko, et al.
Publicado: (2021)

Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ
por: Meurs, Claudia J. C., et al.
Publicado: (2023)

Prognostic value of ductal carcinoma in situ component in invasive ductal carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis
por: Wu, San-Gang, et al.
Publicado: (2018)

A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers
por: Meurs, Claudia J. C., et al.
Publicado: (2018)

Ductal carcinoma in situ diagnosed using an ultrasound-guided 14-gauge core needle biopsy of breast masses: can underestimation be predicted preoperatively?
por: Park, Sung Hee, et al.
Publicado: (2014)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Analysis of Local Recurrence Risk in Ductal Carcinoma In Situ and External Validation of the Memorial Sloan Kettering Cancer Center Nomogram
por: Oses, Gabriela, et al.
Publicado: (2023)

Validation of a Scoring System for Predicting Malignancy in Patients Diagnosed with Atypical Ductal Hyperplasia Using an Ultrasound-Guided Core Needle Biopsy
por: Kim, Jisun, et al.
Publicado: (2012)

Malignant phyllodes tumors of the breast associating malignancy of both mesenchymal and epithelial components (invasive or in situ ductal carcinoma)
por: Nistor-Ciurba, Codruţ-Cosmin, et al.
Publicado: (2020)

Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma
por: Xu, Aqiao, et al.
Publicado: (2022)

External validation of extended prostate biopsy nomogram
por: Hrbáček, Jan, et al.
Publicado: (2015)

Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast
por: Robanus-Maandag, E, et al.
Publicado: (2000)

Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy
por: Chae, Byung Joo, et al.
Publicado: (2009)

Atypical Ductal Hyperplasia of the Breast on Core Needle Biopsy: Risk of Malignant Upgrade on Surgical Excision
por: Bong, Tiffany Sin Hui, et al.
Publicado: (2022)

Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model
por: Meurs, Claudia J. C., et al.
Publicado: (2022)

Synchronous Pancreatic Ductal Adenocarcinomas Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Biopsy
por: Goong, Hyeon Jeong, et al.
Publicado: (2015)

Histopathological grading of breast ductal carcinoma In Situ: validation of a web-based survey through intra-observer reproducibility analysis
por: Schuh, Fernando, et al.
Publicado: (2015)

Nuclear DNA Content of Fine Needle Aspirates of Invasive Ductal Carcinomas of the Breast
por: Sarker, Sudip, et al.
Publicado: (1997)

Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma
por: Xu, Xinsen, et al.
Publicado: (2023)

Identification of aberrant gene expression during breast ductal carcinoma in situ progression to invasive ductal carcinoma
por: Song, Guiqin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hkq193pk3da8gdes0jf367ilk5